Statera Biopharma Inc (STAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2010 | 12-2009 | 09-2009 | 06-2009 | 03-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,214 | 963 | 2,098 | 1,308 | 3,735 |
| Receivables | 2,714 | 3,391 | 2,723 | 3,036 | 1,539 |
| Other current assets | 495 | 381 | 0 | 0 | 0 |
| TOTAL | $8,423 | $4,736 | $5,241 | $4,531 | $5,488 |
| Non-Current Assets | |||||
| PPE Net | 912 | 865 | 866 | 954 | 1,030 |
| Other Non-Current Assets | 987 | 954 | 884 | 806 | 772 |
| TOTAL | $1,899 | $1,818 | $1,751 | $1,759 | $1,802 |
| Total Assets | $10,322 | $6,554 | $6,992 | $6,290 | $7,290 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 859 | 1,209 | 1,278 | 958 | 978 |
| Accrued Expenses | 14,426 | 9,816 | 12,691 | 8,636 | 4,605 |
| TOTAL | $17,611 | $13,354 | $17,303 | $12,131 | $8,008 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 2,326 | 2,330 | 3,333 | 2,337 | 2,384 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $17,611 | $13,354 | $17,303 | $12,131 | $8,008 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,335 | 1,332 | 1,006 | 811 | 731 |
| Common Shares | 133 | 101 | 97 | 79 | 72 |
| Retained earnings | -73,052 | -69,688 | -71,487 | -66,173 | -59,474 |
| Other shareholders' equity | 0 | 0 | 0 | 10 | 14 |
| TOTAL | $-7,289 | $-6,801 | $-10,311 | $-5,841 | $-718 |
| Total Liabilities And Equity | $10,322 | $6,554 | $6,992 | $6,290 | $7,290 |